This article was originally published by Gerard T. Vondeling, Qi Cao, Maarten J. Postma, and Mark H. Rozenbaum in Applied Health […]
The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review Read Post »
Former Congressman Henry Waxman was recently interviewed for the Clause 8 podcast about how he worked together with Sen. Orrin
Clause 8 Podcast Interview with Co-Author of the Hatch-Waxman Act Read Post »
This paper was originally published by Witold Jamróz, Joanna Szafraniec, Mateusz Kurek, and Renata Jachowicz in Pharmaceutical Research September 2018, 35:176 under
There are more than 7,000 diseases that are considered “rare,” that is, affecting fewer than 200,000 Americans. Yet around one
Orphan Drug Patents: Concerns Raised by Payers and Policy Makers Read Post »
A few years ago, there was much talk of the “patent cliff” facing blockbuster drugs like Lipitor and other huge
Why Generic Drug Makers May Benefit from 505(b)(2) Approval Read Post »
This article was originally published by Li Du in BMC Medical Ethics 2018 19:29 under a creative commons license. Abstract
Patenting human genes: Chinese academic articles’ portrayal of gene patents Read Post »
Drug development is one of the world’s most high-risk / high-reward industries, with the vast majority of drugs created never
The 505(b)(2) Drug Patent Approval Process: Uses and Potential Advantages Read Post »
Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities Make Better Decisions answers the following questions
Pharmaceutical Portfolio Management Reading List Read Post »
Artificial intelligence (AI) is the development within computer systems of the ability to perform tasks that have traditionally required human
How Artificial Intelligence Will Affect Healthcare and Drug Prices Read Post »
Get fresh news and insights, drug patent expirations & more…
